Technical Difficulties. If technical difficulties are encountered at xxx.xxxxxx.xxx, applicants should contact Customer Service at xxx.xxxxxx.xxx. The xxx.xxxxxx.xxx Contact Center is available 24 hours a day, 7 days a week, except federal holidays. The Contact Center is available by phone at 0-000-000-0000 or by e-mail at xxxxxxx@xxxxxx.xxx. Application submissions sent by e-mail or fax, or on CDs or thumb drives will not be accepted. Please note that xxx.xxxxxx.xxx is managed by HHS.
Technical Difficulties. We cannot always anticipate technical or other difficulties. These difficulties may result in loss of your data, personal settings, or other interruptions to the Products and Services. We have no responsibility for the timeliness, deletion, mis-delivery, or failure to store any user data, communications, or personal settings with the Products and Services.
Technical Difficulties. If it becomes apparent to either KBI Biopharma or Client at any stage in the provision of any Services that, as a result of scientific or technical reasons out of the reasonable control of either Party, it will not be possible to complete the Services in the manner described in this Agreement or the Proposal or any Change Order thereto, the Parties will (a) identify the problem, (b) submit the problem in writing to senior management of each Party, and (c) negotiate in good faith for a thirty (30) day period from the date senior management of the Parties first convene regarding how to resolve such problem in a commercially reasonable manner. If the Parties do not agree on a commercially reasonable resolution to the problems within such thirty (30) day period, KBI Biopharma and Client shall each have the right to terminate this Agreement by written notice to the other Party, subject to Section 24.2.
Technical Difficulties. When using any EFT service, you may experience technical or other difficulties. We will attempt to post alerts on our website or send you a message to notify you of these interruptions. We cannot assume responsibility for any technical or other difficulties or any resulting damages that you may incur.
Technical Difficulties. There may be times when, for whatever reason, electronic communication to or from the Provider, or access or use of the Service is delayed, impaired or impossible (collectively, “Technical Difficulties”). Should you experience any Technical Difficulties promptly contact the Provider’s Subscriber Service using the contact information provided online. In no event shall the Provider be liable to you for any loss of information, blockages or delays affecting data, information, notifications, purchases, deliveries or any other aspect of the Service due to Technical Difficulties.
Technical Difficulties. If it becomes apparent to either KBI Biopharma or Client at any stage in the provision of any Services that, as a result of scientific or technical reasons out of the reasonable control of either Party, it will not be possible to complete the Services in the manner described in this Agreement or the Proposal or any Change Order thereto, the Parties will (a) identify the problem, (b) submit the problem in writing to senior management of each Party, and (c) negotiate in good faith for a sixty (60) day period from the date senior management of the Parties first convene regarding how to resolve such problem in a commercially reasonable manner.
Technical Difficulties. 1. Employees are responsible for immediately reporting to their supervisor any technical issues they may be experiencing that are preventing them from teleworking.
Technical Difficulties. If you experience a technical failure or interruption of service that causes your funding transaction to fail, you may request that your transaction be completed at a later time. Special Provisions Applicable to Advertisers
Technical Difficulties. If it becomes apparent to either ICOS or PDL at any stage in the provision of any Services that, as a result of scientific or technical reasons out of the reasonable control of either party, it will not be possible to complete the Services in the manner described in this Agreement or the applicable Work and Quality Statements, the parties shall [*] to resolve such problems in a commercially reasonable manner.
Technical Difficulties. There will be technicians ready to assist you with any technical difficulties you may have accessing the special meeting live audio webcast. Please be sure to check in by 8:45 a.m. Atlantic Time on December 10, 2021, (fifteen (15) minutes prior to the start of the meeting is recommended) the day of the meeting, so that any technical difficulties may be addressed before the special meeting live audio webcast begins. If you encounter any difficulties accessing the webcast during the check-in or meeting time, or you have any questions regarding how to use the virtual meeting platform, please call the technical support number that will be posted on the virtual shareholder meeting log in page. Purpose of the Special Meeting At the special meeting, Triple-S stockholders will be asked to consider and vote on the following: • A proposal to approve and adopt the merger agreement, which is further described in the sections entitled ‘‘The Merger (Proposal 1)’’ and ‘‘The Merger Agreement,’’ beginning on pages 31 and 57, respectively, of this proxy statement; • A proposal to approve, on a non-binding, advisory basis, certain compensation that will or may be paid by Triple-S to its named executive officers that is based on or otherwise relates to the merger, which is discussed under the section entitled ‘‘The Merger (Proposal 1)—Interests of Triple-S’s Directors and Executive Officers in the Merger’’ beginning on page 50 of this proxy statement; and • A proposal to approve an adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies in favor of the merger proposal, if there are not sufficient votes at the time of such adjournment to approve the merger proposal. Triple-S stockholders must approve the merger proposal for the merger to occur. If Triple-S stockholders fail to approve the merger proposal, the merger will not occur. The vote on executive compensation payable in connection with the merger is a vote separate and apart from the vote to approve the merger proposal. Accordingly, a stockholder may vote to approve the executive compensation payable in connection with the merger and vote not to approve the merger proposal and vice versa. Because the vote on executive compensation is advisory in nature only, it will not be binding on either Triple-S or Parent. Accordingly, because Triple-S is contractually obligated to pay the compensation, the compensation will be payable, subject only to the conditions applicable thereto, if t...
